Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Prostate cancer screening Stories

2013-12-18 08:28:09

The Prostate Cancer Roundtable has updated its shared national policy agenda for 2014 to include a new policy priority, that Phase III clinical trials of new drugs and treatment be evaluated for their impact on patient-reported quality of life WASHINGTON, Dec. 18, 2013 /PRNewswire/ -- The Prostate Cancer Roundtable has updated its shared national policy agenda for 2014 to include a new policy priority, based on the idea that Phase III clinical trials of new drugs and other forms of...

2013-12-11 23:25:26

Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. Manhasset, NY (PRWEB) December 11, 2013 Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. The findings are published online in CANCER. Prostate cancer is one of the most common cancers in men, with an estimated 240,000 new cases diagnosed...

2013-12-10 10:21:24

Data from the National Lung Cancer Screening Trial (NLST)—conducted by the American College of Radiology Imaging Network and National Cancer Institute Lung Screening Study—provided researchers the opportunity to investigate the probability that a cancer detected with screening low-dose computed tomography (LDCT) would not have progressed to become life threatening. The results of this investigation published online today in JAMA Internal Medicine suggest that up to 18 percent of the...

2013-11-21 23:25:56

Globalsurance has recently released a new blog article on the recent developments in prostate cancer detection. (PRWEB) November 21, 2013 In light of "Movember", the popular worldwide charity for raising funds and awareness for prostate cancer, Globalsurance has released a new blog article which discusses some of the recent scientific breakthroughs in prostate cancer detection and explains the difference between aggressive and non-aggressive prostate cancer. The article begins...

2013-10-28 16:23:23

NORWALK, Conn., Oct. 28, 2013 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the leading online community for medical professionals working in oncology, offers special coverage of Prostate-Specific Antigen (PSA) screening online and in the October issue of the journal ONCOLOGY. Coverage includes review articles, commentaries, and a special PRO/CON feature where oncologists debate two sides of controversial topics. Among the special coverage: -- Should All Colorectal...

2013-10-23 16:29:49

SARASOTA, Fla., Oct. 23, 2013 /PRNewswire/ -- Prostate Cancer expert Dr. Ronald Wheeler, M.D., along with contributing radiologists, has authored a clinical study demonstrating the use of MRI in the diagnosis and treatment of prostate cancer indicating a greater than 99% rate of cure when combined with High Intensity Focused Ultrasound treatment. The Diagnostic Center for Disease in Sarasota, Florida studied more than 140 patients and tracked their progress for up to 72 months....

2013-10-08 12:28:17

LifeAgain BlueMetric Select Term Life Insurance - First Program Designed for Men with Active Localized Prostate Cancer SAN DIEGO, Oct. 8, 2013 /PRNewswire/ -- LifeAgain Insurance Solutions, Inc., a wholly-owned subsidiary of Cardium Therapeutics, today announced support of the American Cancer Society's recommendation that men have the opportunity to make informed decisions about early screening for prostate cancer. Two initial tests commonly used to screen for prostate cancer when...

2013-10-02 08:31:07

LINTHICUM, Md., Oct. 2, 2013 /PRNewswire/ -- With September marking the kickoff of the pro-football season and National Prostate Cancer Awareness Month, the Urology Care Foundation and the National Football League (NFL) teamed up to release a new Public Service Announcement (PSA) focused on educating men about prostate cancer and encouraging them to join the Know Your Stats(®) campaign. To view the multimedia assets associated with this release, please click:...

2013-09-30 13:57:37

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented on Monday by Professor Mathieu Boniol, at the 2013 European Cancer Congress (ECC2013). Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the...

2013-09-30 08:29:17

SAN DIEGO and VANCOUVER, British Columbia, Sept. 30, 2013 /PRNewswire/ -- GenomeDx Biosciences Inc, announced today it has closed a Series B financing round led by Merck Global Health Innovation Fund (GHIF) and other investors including Baird Capital Partners, aeris CAPITAL AG and CD Ventures. This additional capital will be used to further expand the commercialization of the Decipher(TM) prostate cancer test, the first and only commercially available genomic test that predicts the...